HYPERCALCIURIA IN PARATHYROID DISORDERS - EFFECT OF DIETARY-SODIUM CONTROL

被引:6
作者
MULDOWNEY, FP
FREANEY, R
MULDOWNEY, WP
MURRAY, F
机构
[1] NATL UNIV IRELAND UNIV COLL DUBLIN, DEPT MED, DUBLIN 4, IRELAND
[2] UNIV CALIF SAN FRANCISCO, SAN FRANCISCO GEN HOSP, DIV RENAL, SAN FRANCISCO, CA 94110 USA
关键词
HYPERCALCIURIA; PARATHYROID HORMONE; PRIMARY HYPERPARATHYROIDISM; HYPOPARATHYROIDISM; URINE;
D O I
10.1016/S0272-6386(12)80482-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Moderate dietary Na restriction (80 mmol/d for 7 days) during constant Ca intake can reduce high urinary Ca excretion to normal levels in idiopathic hypercalciuria (IH). A similar protocol was used to test its effect in primary hyperparathyroidism (PHPT) and also in hypoparathyroid subjects (HOPT) during treatment with dihydrotachysterol (DHT). Nine subjects with PHPT, 10 with HOPT, and one with pseudo-HOPT were evaluated after Na-restricted (80 mmolld) and Na-supplemented (200 mmolld) diets for 7 days each with dietary Ca constant. Na restriction resulted in a decrease in mean urinary 24-hour Ca excretion in PHPT subjects (10.6 v 7.6 mmol/d [424 v 304 mg], P < 0.0001) and in one pseudo-HOPT subject, similar to the pattern seen previously in IH subjects. In contrast, Na restriction was not accompanied by significant change in Ca excretion in HOPT. There was no change in serum immunoreactive PTH (iPTH) or 1,25(OH)2vitamin D levels in either group when Na intake was altered. Thus, the presence of parathyroid hormone (PTH) is necessary for sodium-related alterations in urinary Ca to occur. The effect of PTH appears to be “permissive” rather than “active”. Dietary Na restriction may have a role in the management of hypercalciuria in mild PHPT cases when parathyroidectomy is contraindicated. © 1991, National Kidney Foundation, Inc.. All rights reserved.
引用
收藏
页码:323 / 329
页数:7
相关论文
共 25 条
[1]   THE ROLE OF DIETARY-SODIUM ON RENAL EXCRETION AND INTESTINAL-ABSORPTION OF CALCIUM AND ON VITAMIN-D METABOLISM [J].
BRESLAU, NA ;
MCGUIRE, JL ;
ZERWEKH, JE ;
PAK, CYC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 55 (02) :369-373
[2]   CHANGES IN SERUM AND URINARY CALCIUM DURING TREATMENT WITH HYDROCHLOROTHIAZIDE - STUDIES ON MECHANISMS [J].
BRICKMAN, AS ;
COBURN, JW ;
MASSRY, SG .
JOURNAL OF CLINICAL INVESTIGATION, 1972, 51 (04) :945-&
[3]   PARATHYROID-HORMONE IN SODIUM-DEPENDENT HYPERTENSION [J].
DORIS, PA ;
HARVEY, S ;
PANG, PKT .
LIFE SCIENCES, 1987, 41 (11) :1383-1389
[4]   A COMPARISON OF THE PERFORMANCE AND CLINICAL UTILITY OF MID-MOLECULAR AND C-TERMINAL PARATHYROID-HORMONE ASSAYS [J].
FREANEY, R ;
QUINN, M ;
MULDOWNEY, FP .
JOURNAL OF AUTOMATIC CHEMISTRY, 1987, 9 (04) :174-178
[5]  
HINE JJ, 1987, ANN CLIN BIOCHEM, V24, pS149
[6]   THE URINARY EXCRETION OF CALCIUM AND INORGANIC PHOSPHATE IN 344 PATIENTS WITH CALCIUM STONE OF RENAL ORIGIN [J].
HODGKINSON, A ;
PYRAH, LN .
BRITISH JOURNAL OF SURGERY, 1958, 46 (195) :10-18
[7]   EFFECTS OF ATRIAL NATRIURETIC FACTOR ON RENAL HANDLING OF WATER AND ELECTROLYTES IN RATS [J].
KEELER, R ;
AZZAROLO, AM .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1983, 61 (09) :996-1002
[8]   THE METABOLISM AND MECHANISM OF ACTION OF 1,25-DIHYDROXYVITAMIN-D3 [J].
KUMAR, R .
KIDNEY INTERNATIONAL, 1986, 30 (06) :793-803
[9]   CALCIUM-REGULATING HORMONES AND THE KIDNEY [J].
KUROKAWA, K ;
YAMAMOTO, M ;
HARRINGTON, JT ;
TAKAICHI, K ;
MATSUMOTO, T ;
MATSUNAGA, H ;
SUZUKI, M .
KIDNEY INTERNATIONAL, 1987, 32 (05) :760-771
[10]  
LEMANN J, 1979, NEW ENGL J MED, V301, P535, DOI 10.1056/NEJM197909063011008